Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
000990.SZ
HOLDREMOVEChengzhi Co., Ltd. · Healthcare · China · $1.7B · Avg Vol: $52M/d
Chengzhi Co. is a Chinese chemical and clean energy company. It is a capital-intensive commodity business with low quality metrics and high exposure to volatile petrochemical feedstocks.
COMPANY DESCRIPTION
Chengzhi Co., Ltd. operates in industrial gas production, coal chemical processing, and high-tech materials like liquid crystals. The company holds a strong market position in clean energy chemicals and is a key domestic supplier of liquid crystal materials for displays. It is a diversified high-tech industrial enterprise backed by Tsinghua University's historical technology ecosystem.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 1.7B | 1.8B | 1.6B | 1.6B | -2.0% |
| EPS | 0.01 | 0.02 | 0.03 | -0.01 | 112.8% |
| Shares | 1.2B | 1.2B | 1.2B | 1.2B | 0.0% |
| Debt | 522M | 693M | 879M | 949M | 22.1% |
| Equity | 2.6B | 2.6B | 2.6B | 2.6B | -0.2% |
| Op CF | 200M | 205M | 204M | 159M | -7.4% |
| Inv CF | -229M | -56M | -398M | -154M | — |
| Fin CF | -33M | -9M | 112M | -7M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000990.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000990.SZ | Chengzhi Co., Ltd.(you) | $1.7B | 63 | HOLD |
| 002287.SZ | Tibet Cheezheng Tibetan Medicine Co., Ltd. | $1.8B | 60 | HOLD |
| 688105.SS | Nanjing Vazyme Biotech Co., Ltd | $1.1B | 63 | HOLD |
| 002030.SZ | Daan Gene Co., Ltd. | $1.5B | 57 | HOLD |
| 2315.HK | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | $2.8B | 61 | HOLD |
| 688513.SS | Chengdu Easton Biopharmaceuticals Co., Ltd. | $1.4B | 55 | HOLD |
| 688046.SS | GemPharmatech Co., Ltd. | $1.2B | 70 | BUY |
| 688253.SS | Innovita Biological Technology Co., Ltd. | $1.1B | 58 | HOLD |
| 301047.SZ | Sino Biological,Inc. | $1.1B | 70 | BUY |
| 605116.SS | Aurisco Pharmaceutical Co.,Ltd. | $1.2B | 56 | HOLD |
Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%